glp-1 hormones Glucagon-like peptide-1 Glucagon-like peptide (GLP)-1 and GLP-2

Dula (50, 100, and 150 g/kg) substantially reduced the colon's weight, the ratio of weight to length, serum CRP, and LDH levels, boosted histopathological alterations and displayed anti-colitis and anti-inflammatory actions

About Us Careers Partner with us Forgot password

These tools can help address barriers posed by in-person visits, enhance patient engagement, and promote adherence to nutritional and lifestyle recommendations

Critics of GLP-1 therapies often portray those who use these medications as opting for an easy way out to achieve thinness, perpetuating longstanding biases like those historically associated with bariatric surgery (Heitmann, 2025)

However, clinical implementation should be personalised, recognising interindividual variability and sex-specific differences in response